CFG
CATX icon

Citizens Financial Group’s Perspective Therapeutics CATX Stock Holding History

Citizens Financial Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-53,100
Closed -$182K – 817
2025
Q3 		$182K Hold
53,100
– – ﹤0.01% 772
2025
Q2 		$183K Sell
53,100
-46,900
-47% -$124K ﹤0.01% 672
2025
Q1 		$213K Buy
100,000
+50,000
+100% +$150K ﹤0.01% 576
2024
Q4 		$160K Buy
+50,000
New +$408K ﹤0.01% 567

Other funds holding CATX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citizens Financial Group's CATX Position: Q4 2025 in Review

Citizens Financial Group sold out of Perspective Therapeutics (CATX) in Q4 2025, closing a stake of 53,100 shares — an estimated $182K sold.

Citizens Financial Group first reported a position in CATX in Q4 2024 and held it in 4 quarters. The position peaked at $213K in Q1 2025. 117 funds tracked by Wall St. Rank hold CATX as of Q4 2025.

  • Citizens Financial Group reported no remaining Perspective Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Citizens Financial Group sold 53,100 Perspective Therapeutics shares in Q4 2025, an estimated $182K.
  • Citizens Financial Group first reported a position in Perspective Therapeutics in Q4 2024 and held it in 4 quarters.
  • Citizens Financial Group's Perspective Therapeutics position peaked at $213K in Q1 2025.
  • 117 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2025.

Based on Citizens Financial Group's 13F filing for Q4 2025, filed 30 Jan 2026.